Zurück zu den Rankings

Central Garden & Pet Company (CENTA)

POSITIVE
Consumer DefensivePackaged FoodsUnited States

Fundamental

78

Kurs

$38.22

Marktkapitalisierung

$2.42B

Teil 1 · Was das Unternehmen wert ist

Übersicht

Central Garden & Pet Company produces and distributes various products for the lawn and garden, and pet supplies markets in the United States. It operates through two segments: Pet and Garden. The Pet segment provides dog and cat supplies, such as dog treats and chews, toys, pet beds and containment, grooming items, waste management, and training pads; supplies for aquatics, small animals, reptiles, and pet birds, including toys, enclosures, habitats, bedding, and food and supplements; products for equine and livestock; animal and household health and insect control products; aquariums and terrariums, including fixtures and stands, water conditioners and supplements, water pumps and filters, and lighting systems and accessories; and live fish and small animals, as well as outdoor cushions. This segment sells its products under the Aqueon, Cadet, Comfort Zone, Farnam, Four Paws, K&H Pet Products, Kaytee, Nylabone, and Zilla brands. Its Garden segment offers lawn and garden supplies products that include grass seed; vegetable; flower and herb packet seed; wild bird feed, bird feeders, bird houses, and other birding accessories; fertilizers; decorative products; live plants; and weed and grass, as well as other herbicides, insecticide, and pesticide products. This segment sells its lawn and garden supplies products under the Amdro, Ferry-Morse, Pennington, and Sevin brands. The company sells its products to independent distributors, big-box retailers, national and regional retail chains, eCommerce and online retailers, grocery stores, nurseries, and mass merchants. Central Garden & Pet Company was founded in 1955 and is headquartered in Walnut Creek, California.

No editorial profile for this company yet

Direct competitors

Who this company fights with for the same customers

No editorial profile for this company yet

No competitor list for this company yet.

Bilanz & Liquidität

Umsatz

$3.08B

Letzte 12 Monate (bis 27.6.2026)

Nettogewinn

$166M

Letzte 12 Monate (bis 27.6.2026)

Freier Cashflow

$291M

Gesamtes Eigenkapital

$1.58B

Gesamtverbindlichkeiten

$2.04B

Current Ratio

3.79

Zinsdeckungsgrad

4.37

Schulden/EBITDA

4.21

Gewinn je Aktie

Umsatz & Nettogewinn

Freier Cashflow

Ertragsaufschlüsselung

Historische Aufstellung

Margen im Zeitverlauf

Verschuldung im Zeitverlauf

Wie schwer die Schulden wiegen

Wachstumsraster

Wachstum — Umsatz

Innerer-Wert-Schätzung

General caseUnterbewertet

Innerer Wert

$121.14

Aktueller Kurs

$38.22

Sicherheitsmarge

+68.5%

Innerer-Wert-Spanne

$78.74 - $163.55

Bewertungsmethoden

Analyst price target:$46.25
Discounted cash flow (DCF):$526.12
Earnings multiple (P/E):$38.00
Graham growth formula:$34.21
Earnings power value (EPV):$40.17
Justified P/B:$36.04
Dividend discount (Gordon):Not enough data to compute it
P/FFO, funds from operations:Not enough data to compute it
Mid-cycle earnings:$266.78
Revenue multiple:Not enough data to compute it
Analystenkonsens:Starker Kauf (9B / 1H / 1S)
Letzte Gewinnüberraschung:-1.45%

Bewertungskennzahlen

P/E-Verhältnis

14.31

ROE

10.3%

P/B-Verhältnis

0.27

P/FCF

1.36

Bruttomarge

32.5%

ROIC

6.1%

Rentabilitäts-Radar

Value Creation (Economic Moat)

ROIC

6.1%

WACC

6.4%

ROIC − WACC

-0.3 pp

ROIC is roughly in line with the cost of capital — the company is barely covering its capital cost.

Fundamentalanalyse-Kriterien

Bestanden (23)

  • EPS shows upward trend
  • EPS CAGR 6.44%
  • ROIC 6.1%
  • Gross Margin 32.5%
  • P/FCF 1.36
  • P/B Ratio 0.27
  • Debt/Equity ratio
  • Operating Margin 8.1%
  • Positive Free Cash Flow
  • CapEx intensity
  • Current Ratio
  • Interest Coverage
  • Debt/EBITDA
  • Return on Tangible Assets
  • Price below Graham Number
  • DCF valuation (Undervalued)
  • ROE 10.7%
  • Analyst Consensus 82% Buy
  • Earnings Surprise avg 29.5%
  • Earnings Quality (OCF/NI) 2.35
  • Share Dilution -4.2%
  • Net Margin Trend 5.4% vs 4.4%
  • Piotroski F-Score 7/9

Nicht bestanden (4)

  • Price CAGR 4.51%
  • Low reliance on intangibles
  • Revenue Growth 5Y 3.0%
  • PEG Ratio 4.96

Nicht verfügbar (1)

  • Dividend Payout NaN%

Piotroski F-Score

7/9

Starke finanzielle Gesundheit

score
criteria

Gewinnqualität

2.35

Hohe Qualität: Gewinne durch Cashflow gedeckt

Aktienverwässerung

-4.2%

Aktienrückkäufe. Aktionärsfreundlich

Unternehmensführung

Führungsteam

NamePositionAlter
Mr. William E. BrownFounder & Chairman84
Mr. Nicholas LahanasCEO & Director56
Mr. Bradley G. SmithChief Financial Officer59
Mr. John D. Walker IIIPresident of Garden Consumer Products67
Mr. John Edward HansonPresident of Pet Consumer Products60
Mr. Howard A. Machek CPASenior VP & Chief Accounting Officer62
Mr. Chris WalterSenior VP & Chief Information Officer-
Ms. Friederike EdelmannVice President of Investor Relations-
Mr. Apur PatelChief Legal Officer-
Ms. Marilyn LeahySenior Vice President of Human Resources-

Teil 2 · Der Preis und der Einstiegszeitpunkt

Dieser Teil sagt nicht, ob das Unternehmen etwas taugt: Er hilft bei der Wahl des Kaufzeitpunkts, nachdem die Fundamentaldaten überzeugt haben. Enthalten: technische Analyse, Potenzial, historische Drawdowns, Gamma-Exposure.

Latest News

Recent headlines for CENTA, sourced from Markets Gazette.

No recent news for CENTA.